Font:
CO

COHANCE / NSE / Biotechnology & Drugs

Cohance Lifesciences

INR 440.116.65 (2.14%) 1D
Last updated: 2026-06-15T16:37:40.262172+00:00
Price Chart

1Y Price Trend

Open1,015
High1,121.15
Low266.7
Close426.95
Volume3,50,791
Change-588.05
Change %-57.94%

Key Information

Ticker SymbolCOHANCE
Current Price440.1
52-Week High1,121.15
52-Week Low266.7
Market Cap17,078.84
Beta1.18
Volume3,50,791
ISININE03QK01018
Day High434.95
Day Low422.7
Open428.95

Recommendations

RatingHold

Target High1,121.15

Target Low267.85

Target Mean3.25

Target Median81.25

Risk Metrics

Overall RiskHigh risk

Board Risk56.8

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

FAQ

Stock FAQs

What is the NSE symbol for Cohance Lifesciences?

Cohance Lifesciences trades on NSE with the symbol COHANCE. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Cohance Lifesciences share price and chart?

You can track Cohance Lifesciences share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Cohance Lifesciences?

Yes. ShareKeyX displays available financial statements for Cohance Lifesciences using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Cohance Lifesciences?

Yes. ShareKeyX displays available historical OHLC candles for Cohance Lifesciences across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Cohance Lifesciences belong to?

Cohance Lifesciences is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Cohance Lifesciences?

Yes. ShareKeyX shows the latest available stock news for Cohance Lifesciences from the connected stock news source.